Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

The Pharmaceutical Industry — Prices and Progress

9 references·6 citing·45 second hop

FromToDepth

this work references cited by second hop

References

1966The Logic of Collective Action: Public Goods and the Theory of Groups.11,518 cited
1971Industrial Market Structure and Economic Performance.6,267 cited
2003The price of innovation: new estimates of drug development costs4,264 cited
2000Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not)3,045 cited
1990Industrial market structure and economic performance2,573 cited
2000Technology policy for a world of skew-distributed outcomes625 cited
1993Pricing, Profits, and Technological Progress in the Pharmaceutical Industry255 cited
1998Strategic Pricing of New Pharmaceuticals249 cited
2001The Link Between Gross Profitability And Pharmaceutical R&D Spending183 cited

Cited by

2005The Patents-Based Pharmaceutical Development Process98 cited
2019Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies90 cited
2014Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders73 cited
2015Effectiveness, safety and costs of orphan drugs: an evidence-based review72 cited
2010How New Zealand has contained expenditure on drugs

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

61 cited

2010Sanofi-Aventis and the Complexity of Capitalist Organization32 cited